<\/b><\/p>\n
<\/b><\/p>\n
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 9 to 13, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n
Statins Tied to Lower In-Hospital COVID-19 Mortality Risk<\/strong><\/p>\n FRIDAY, Nov. 13, 2020 (HealthDay News) — Treatment with statins prior to and during a COVID-19-related hospitalization is associated with lower COVID-19-related in-hospital mortality, according to a study published online Nov. 2 in the European Heart Journal: Cardiovascular Pharmacotherapy<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n ACR: Incidence of COVID-19 Low in Patients With Rheumatic Disease<\/strong><\/p>\n FRIDAY, Nov. 13, 2020 (HealthDay News) — Patients with rheumatic disease have a low incidence of COVID-19 and most have mild disease, according to research presented at ACR Convergence, the annual meeting of the American College of Rheumatology, held virtually from Nov. 5 to 9.<\/p>\n Read Full Text<\/a><\/p>\n Mental Health ED Visits in Children Up Mid-March to October 2020<\/strong><\/p>\n FRIDAY, Nov. 13, 2020 (HealthDay News) — From mid-March to October 2020, there was an increase in the proportion of mental health-related emergency department visits among children and adolescents, according to research published in the Nov. 13 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n U.S. Nursing Homes Seeing Increase in New COVID-19 Cases<\/strong><\/p>\n THURSDAY, Nov. 12, 2020 (HealthDay News) — Nursing homes are seeing an increase in new COVID-19 cases, paralleling an increase in the general U.S. population, according to a report published online Nov. 10 by the American Health Care Association and National Center for Assisted Living.<\/p>\n Read Full Text<\/a><\/p>\n AHA: Patient CPR Outcomes Similar With COVID-19 Precautions<\/strong><\/p>\n THURSDAY, Nov. 12, 2020 (HealthDay News) — For patients receiving cardiopulmonary resuscitation, outcomes during COVID-19 were similar to those in 2019, according to a study presented at the American Heart Association Resuscitation Science Symposium 2020, to be held virtually from Nov. 14 to 16 as part of the annual meeting of the American Heart Association.<\/p>\n Read Full Text<\/a><\/p>\n COVID-19 at Forefront of IDWeek Discussions<\/strong><\/p>\n THURSDAY, Nov. 12, 2020 (HealthDay News) — Emerging COVID-19 science, including epidemiology, treatments, vaccines, and post-COVID-19 syndrome took center stage at this year’s IDWeek, the annual meeting of infectious disease experts worldwide, held virtually from Oct. 21 to 25. HD Live! sat down with IDWeek chairs Inger Damon, M.D., director of the U.S. Centers for Disease Control and Prevention Division of High-Consequence Pathogens and Pathology, and Tom Talbot, M.D., professor of medicine at the Vanderbilt University School of Medicine in Nashville, Tennessee, to break down the key takeaways of this year’s meeting.<\/p>\n Read Full Text<\/a><\/p>\n 9 Percent Readmitted After Index COVID-19 Hospitalization<\/strong><\/p>\n THURSDAY, Nov. 12, 2020 (HealthDay News) — Among patients surviving an index COVID-19 hospitalization, 9 percent are readmitted within two months of discharge, according to research published in the Nov. 9 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19<\/strong><\/p>\n THURSDAY, Nov. 12, 2020 (HealthDay News) — Hydroxychloroquine is not beneficial for adults hospitalized with COVID-19, according to the formal conclusion of a study funded by the U.S. National Heart, Lung, and Blood Institute and published online Nov. 9 in the Journal of the American Medical Association<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Many at Risk for Severe COVID-19 Have Essential Jobs<\/strong><\/p>\n TUESDAY, Nov. 10, 2020 (HealthDay News) — Between 56.7 and 74.3 million U.S. adults are at increased risk for severe COVID-19 and are either themselves an essential worker or live with one, according to a research letter published online Nov. 9 in JAMA Internal Medicine<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Intentional Violent Injuries Up During Peripandemic Period<\/strong><\/p>\n TUESDAY, Nov. 10, 2020 (HealthDay News) — The proportion of intentional violent injuries increased during the peripandemic months, especially from firearms, according to a study published online Nov. 6 in the Journal of the American College of Surgeons<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Antibody Treatment Approved for Emergency Use Against Early COVID-19<\/strong><\/p>\n TUESDAY, Nov. 10, 2020 (HealthDay News) — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency approval by the U.S. and Food Administration on Monday.<\/p>\n Read Full Text<\/a><\/p>\n COVID-19 Infection Higher Among Support Staff Than Doctors, Nurses<\/strong><\/p>\n TUESDAY, Nov. 10, 2020 (HealthDay News) — Support staff in health care settings have higher COVID-19 infection rates than physicians and nurses, according to a study published online Oct. 31 in Open Forum Infectious Diseases<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Preexisting Tinnitus May Be Exacerbated by COVID-19<\/strong><\/p>\n MONDAY, Nov. 9, 2020 (HealthDay News) — Preexisting tinnitus may be exacerbated by COVID-19, although more than half of patients experience no change in symptoms, according to a study published online Nov. 5 in Frontiers in Public Health<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Pfizer COVID-19 Vaccine Reaches 90 Percent Effectiveness in Early Analysis<\/strong><\/p>\n MONDAY, Nov. 9, 2020 (HealthDay News) — A new vaccine developed by Pfizer and the German biotechnology firm BioNTech was more than 90 percent effective at protecting people from COVID-19, an interim analysis released Sunday shows.<\/p>\n Read Full Text<\/a><\/p>\n Hospital Stays After Delivery Shorter With Pandemic Protocols<\/strong><\/p>\n MONDAY, Nov. 9, 2020 (HealthDay News) — Although maternal and newborn length of stay in the hospital after delivery is significantly shorter following policy modifications put in place due to the COVID-19 pandemic, no increases in the rate of adverse maternal or neonatal outcomes have been observed, according to a study published in the November issue of the American Journal of Obstetrics and Gynecology: Maternal-Fetal Medicine<\/em>.<\/p>\n